Nasdaq-listed health sciences firm Prenetics Global has made headlines once again, this time by raising $48 million in an oversubscribed equity round aimed at accelerating its Bitcoin treasury strategy and expanding its fast-growing supplement brand IM8, co-founded with football legend David Beckham.
This move places Prenetics among the growing list of publicly traded companies diversifying their balance sheets with Bitcoin, a trend that continues to gain traction as digital assets evolve into a recognized store of value.
Crypto-Focused Investors Join the Round
Prenetics’ latest fundraising attracted strong interest from several high-profile investors within the crypto and traditional finance sectors. The round included participation from Kraken, Exodus, GPTX by Jihan Wu, DL Holdings, and American Ventures, showcasing the growing intersection between blockchain investors and mainstream businesses.
Prominent individual investors also took part in the round. Tennis star Aryna Sabalenka and Hong Kong billionaire Adrian Cheng both increased their holdings in Prenetics, reflecting confidence in the company’s dual focus on digital assets and consumer health innovation.
According to Prenetics, the gross proceeds of this equity offering amount to approximately $48 million, with the potential to reach $216 million if all associated warrants are exercised.
Bitcoin Treasury Strategy Gains Momentum
Prenetics CEO Danny Yeung emphasized that the fresh capital will not only fund the company’s expansion in the health and wellness sector but will also bolster its Bitcoin accumulation initiative.
The company first announced its Bitcoin treasury plan in June 2025, committing to a daily purchase of 1 BTC starting August 1. As of October 27, Prenetics holds roughly 275 BTC, valued at around $31 million. Following the completion of this funding round, the firm expects to hold total liquidity of approximately $131 million.
In Yeung’s words, the company’s long-term strategy is “bold yet realistic.” He added that Prenetics’ goal is to achieve $1 billion in annual revenue and $1 billion in Bitcoin holdings within the next five years — a vision that reflects both technological foresight and financial conviction.
This makes Prenetics one of the first major Nasdaq-listed health companies to adopt a Bitcoin-centric balance sheet approach, aligning it with tech-forward firms like MicroStrategy that have made similar moves.
IM8: A Rapidly Expanding Global Brand
Alongside its Bitcoin strategy, Prenetics continues to grow IM8, its nutritional supplement brand co-founded with David Beckham. The brand has become one of the company’s key growth engines, blending celebrity influence with science-backed health innovation.
Since launching in late 2024, IM8 has achieved remarkable traction. Within 11 months, it generated $100 million in recurring revenue, a figure that signals both strong consumer demand and effective brand positioning. Prenetics projects IM8’s revenue to reach between $160 million and $200 million in 2026, driven by global expansion efforts in Asia, Europe, and North America.
The combination of health science credibility and Beckham’s global appeal has helped IM8 capture attention in an increasingly crowded wellness market. Yeung stated that the new funding will accelerate IM8’s entry into new territories and strengthen its product development pipeline.
Balancing Health Innovation with Digital Asset Growth
Prenetics’ decision to integrate Bitcoin into its financial ecosystem may seem unconventional for a health sciences company, but it reflects a broader trend among forward-looking corporations. As inflationary pressures persist and fiat currencies face uncertainty, more firms are exploring Bitcoin as a treasury reserve asset.
The company’s approach is notably disciplined. By purchasing 1 BTC daily rather than in large lump sums, Prenetics minimizes timing risk while steadily building a long-term position. This “dollar-cost averaging” strategy mirrors methods used by institutional investors seeking sustainable exposure to Bitcoin.
At the same time, Prenetics continues to diversify its revenue through the health and wellness segment, ensuring operational stability while leveraging Bitcoin as a parallel growth asset.
Market Performance and Investor Sentiment
Despite the positive news, Prenetics’ stock experienced short-term volatility. On Monday, shares of Prenetics (NASDAQ: PRE) fell 21.96% to close at $13.08, according to Yahoo Finance data. However, after-hours trading saw a 4.51% rebound, indicating investor interest in the company’s bold strategic direction.
Over the past six months, Prenetics stock has surged 161.6%, outperforming many peers in both the healthcare and tech sectors. Although it remains down nearly 20% over the past week, analysts note that the company’s mix of crypto exposure and health business diversification provides long-term upside potential.
A Convergence of Two Worlds
Prenetics’ expansion represents the convergence of health innovation and blockchain finance, two industries that are rapidly reshaping global markets. By combining its biotechnology expertise with a digital asset investment strategy, the company is positioning itself as a modern hybrid enterprise — one that understands both consumer wellness trends and the evolving role of digital money.
While some investors may view Bitcoin accumulation as risky for a non-crypto firm, Prenetics’ structured and transparent approach may serve as a model for others looking to hedge against traditional market volatility.
Looking Ahead
With new funding secured and clear growth objectives, Prenetics appears poised for a transformative period. Its commitment to expanding IM8 globally and building a substantial Bitcoin treasury underscores a strategic balance between innovation and diversification.
If the company achieves its target of $1 billion in annual revenue and $1 billion in Bitcoin holdings, it could emerge as a benchmark case study for how traditional industries can integrate digital assets into their financial ecosystems responsibly.
In an era where the lines between technology, finance, and health are blurring, Prenetics Global stands out as a pioneer — bridging the gap between science-backed wellness and the decentralized economy of the future.
Post Views: 26
